A Randomized, Double-blind, Placebo-controlled, Multinational, Phase 3 Study of the Efficacy and Safety of Inhaled Treprostinil in Subjects with Idiopathic Pulmonary Fibrosis (TETON-2) (NCT05255991)
TETON-2
This trial is No longer recruiting
Registration number NCT05255991
Program & service
This trial is being run with the Heart & Lung service, and as part of the Respiratory program.
Trial phase
Phase 3
Trial participation type
This trial has been designed for the Clinical Research of a Drug.
Principal investigator
Associate Professor Ian Glaspole
More information
To find out more about this clinical trial, please review full details on the ANZCTR website.
View on ANZCTR